04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
BCLP’s global Antitrust & Competition team have been tracking the various ways COVID-19 is impactin...
Read More >
The Colorado Department of Labor and Employment’s Division of Labor Standards and Statistics has re...
Read More >
In a previous alert, IRS Adopts Final Regulations Changing Hardship Distributions, we analyzed the I...
Read More >
On July 5, 2019, the Alcohol and Tobacco Tax and Trade Bureau (“TTB”) issued TTB Industry Circular...
Read More >
The federal law known as Title VII, along with similar state laws, prohibits discrimination in emplo...
Read More >
The only certainty, so far in 2020, has been uncertainty. For dealmakers and their advisors this is ...
Read More >